FEATURES OF ANTIBACTERIAL THERAPY OF CHRONIC BACTERIAL PTOSTATITIS ON THE BACKGROUND OF ATYPICAL UROINFECTION

  • V. Feoktistov Non-profit Joint Stock Company "Medical University of Karaganda"
  • M. Amantaeva School of general medicine NJC MUK
  • T. Veisenberg School of general medicine NJC MUK
DOI: https://doi.org/10.31618/ESU.2413-9335.2021.2.84.1283
Keywords: prostatitis, treatment, macrolides

Abstract

This study was made of 87 patients with a chronic bacterial prostatitis complicated by atypical uroinfection. The endocellular pathogens were identified among 38 patients on the background of chronic kidney disease in the acute phase and among 49 patients in the lag phase. There were identified 97 cultures in total. The associative microflora has been submitted by mainly two-componential association and was observed in 19 % cases.

The 6 types of bacteria, by general number 127 of cultures, were allocated in microbiological research of a secret prostate before the beginning of treatment. In 17 monitorings there were associations of culture, in other cases as monocultures. Patients received in tablet form of roxithromycini in a daily dose of 300 mg, azithromycini in a daily dose of 1000 mg and josamycini in a daily dose 1500 mg during 10-14 day. The maximal clinical and bacteriological efficiency of treatment was marked in case of application josamycini.

Author Biographies

V. Feoktistov, Non-profit Joint Stock Company "Medical University of Karaganda"

Assistant Professor of the Department of Surgical Diseases

M. Amantaeva , School of general medicine NJC MUK

5th year student

T. Veisenberg , School of general medicine NJC MUK

5th year student

References

1.Voskanyan G.A. Antibacterial therapy of patients with chronic prostatitis: search for a way out of the therapeutic "dead end" / G.А. Voskanyan, A.Z. Vinarov // Urology.- 2014.- No. 3.- P.89-92.
2. Trukhan N.B., Makushin D.G., Bagisheva N.V. Chronic prostatitis: topical issues of diagnosis and treatment at the stage of providing primary specialized and health care // International Journal applied and fundamental research. -2016.- No. 6- 2.- P.285-291
3. Tiktinsky O. L. Treatment of chronic prostatitis caused by chlamydial and ureaplasma infection and complicated by male infertility / O.L. Tiktinsky, S.N. Kalinina // Urology.-2010.- No. 3.- P.52-57
4. Fu W. The effect of chronic prostatitis / chronic pelvis pain syndrome (CP / CPPS) on semen parameters in human males: a systematic review and metaanalysis / W. Fu, Z. Zhou, S. Liu et al // PLoS One.- 2014.- Vol.4.- P.94991
5. Amirov N.B., Vizel A.A. Macrolides in the treatment of various bacterial infections // Bulletin of modern clinical medicine.-2012, -T-5, No. 4, P.37-41
Published
2021-04-15
How to Cite
Feoktistov, V., M. Amantaeva, and T. Veisenberg. 2021. “FEATURES OF ANTIBACTERIAL THERAPY OF CHRONIC BACTERIAL PTOSTATITIS ON THE BACKGROUND OF ATYPICAL UROINFECTION ”. EurasianUnionScientists 2 (3(84), 61-63. https://doi.org/10.31618/ESU.2413-9335.2021.2.84.1283.
Issue
Vol. 2 No. 3(84) (2021): EURASIAN UNION OF SCIENTISTS №84
Section
Article

CC BY-ND

A work licensed in this way allows the following:

1. The freedom to use and perform the work: The licensee must be allowed to make any use, private or public, of the work.

2. The freedom to study the work and apply the information: The licensee must be allowed to examine the work and to use the knowledge gained from the work in any way. The license may not, for example, restrict "reverse engineering."

2. The freedom to redistribute copies: Copies may be sold, swapped or given away for free, in the same form as the original.